High density lipoprotein and low density lipoprotein-mediated changes in cultured human skin fibroblasts

• Autorzy: Jozwiak Z. , Szosland D. , Rozga B.
• Języki publikacji: EN

Abstrakty

EN

We investigated the effect of native and modified high density lipoprotein (HDL) and low density lipoprotein (LDL) on the viability and the membrane fluidity of normal and diabetic fibroblasts. Under experimental conditions, HDL did not affect the cultured normal cells. Incubation of HDL with diabetic fibroblasts resulted in a negligible decrease in the cell viability and induced an increase in the lipid fluidity at surface of the cell membranes. LDL at the higher concentration reduced the viability both normal and diabetic fibroblasts and also enhanced the fluidity of membrane lipids. The above changes in the fluidity of fibroblast membranes were observed mainly in the presence of native and oxidized lipoproteins and are connected with the differences in the structure of cell membranes and nature of the cytotoxicity of LDL and HDL.

Słowa kluczowe

EN

skin; man; lipoprotein; membrane; fluidity; fibroblast

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 1996
• Tom: 01
• Numer: 2
• Opis fizyczny: p.163-169,fig.

Twórcy

autor

Jozwiak Z.

• University of Lodz, 90-237 Lodz, Poland

autor

Szosland D.

autor

Rozga B.

Bibliografia

• 1. Steinbrecher, U.P., Parthasarathy, S., Leake, D.S., Witztum, J.L. and Steinberg D., Proc. Natl. Acad. Sci. USA, 81 (1984) 3883-3887.
• 2. Esterbauer, H., Dieber-Rotheneder, M., Waeg, G., Striegl, G. and Jurgens, G., Chem. Res. Toxicol. 3 (1990) 77-92.
• 3. Rankin, S.M., Parthasarathy, S. and Steinberg, D.J. Lipid Res. 32 (1991) 449- 456.
• 4. Dousset, N., Negre-Salvayre, A., Lopez, M., Salvayre, R. and Dousti-Blazy, L. Biochim. Biophys. Acta 1045 (1990) 219-223.
• 5. Zhang, A., Vertommen, J., Van Gaal, L. and De Leeuw, I. Clin. Chim. Acta 227 (1994) 159-173.
• 6. Lenz, M.L., Hughes, H., Mitchell, J.R., Via, D., Guyton, J., Taylor, A., Gotto, A. and Smith, C. Lipid Res. 31 (1990) 1043-1050.
• 7. Bhadra, S., Arshad, M., Rymaszewski, Z., Norman, E., Wherley, R. and Subbiah, M. Biochem. Biophys. Res. Commun. 176 (1991) 431-440.
• 8. Sparrow, C., Parthasarathy, S. and Steinberg, D. J. Biol. Chem. 264 (1989) 2599-2604.
• 9. Tertov, V., Sobenin, I., Gabbasov, Z., Popov, E. and Orekhov, A. Biochem. Biophys. Res. Commun. 163 (1989) 489-494.
• 10. Bonneau, C., Couderc, R., Roch-Arveiller, M., Giroud, J. and Raichvarg, D. Biochem. Soc. Trans. 18 (1990) 1188-1189.
• 11. Idohou, N., Roch-Arveiller, M., Bonneau, C., Giroud, J. and Raichvarg, D.J. J. Leukocyte Biol. 50 (1991) 1-9.
• 12. Jóźwiak, Z., Pałecz, D. and Bartosz, G. Biochem. Molec. Biol. Int. 32 (1994) 259-267.
• 13. Schriewer, H., Kochnert, V. and Assmann, G. J. Clin. Chem. Clin. Biochem. 22 (1984) 35-40.
• 14. Satho, K. Clin. Chim. Acta 90 (1987) 37-43.
• 15. Lowry, O.H., Rosebrough, N., Farr, A. and Randall, A. J. Biol. Chem. 193 (1951) 265-275.
• 16. Duell, P., Oram, J. and Bierman, E. Diabetes 393 (1990) 1257-1263.
• 17. Habeeb, A.F. Anal. Biochem. 14 (1966) 328-336.
• 18. Mosmann, T.J. Immunol. Methods 65 (1983) 55-63.
• 19. Shinitzky, M. and Barenholz, Y. Biochim. Biophys. Acta 515 (1978) 367-394.
• 20. Morel, D., Hessler, J. and Chisolm, G. J. Lipid Res. 24 (1983) 1070-1076.
• 21. Hessler, J., Morel, D., Lewis, L. and Chisolm, G. Atheriosclerosis 3 (1983) 215-222.
• 22. Block, L. Klin. Wochenschrift 68 (1991) 60-64.
• 23. Hessler, J., Robertson, A. and Chisolm, G. Atherosclerosis 32 (1979) 213-229.
• 24. Henriksen, T., Evensen, S. and Carlander, B. Scand. J. Clin. Lab. Invest. 39 (1979) 369-375.
• 25. Parthasarathy, S., Barnett, J. and Fong, L. Biochim. Biophys. Acta 1044 (1990) 275-283.